Citizens Maintains Market Outperform on Artivion, Lowers Price Target to $42
Benzinga Newsdesk 7 hours ago
Analyst RatingsNewsPrice Target
Citizens analyst Daniel Stauder maintains Artivion (NYSE:AORT) with a Market Outperform and lowers the price target from $48 to $42.
Citizens analyst Daniel Stauder maintains Artivion (NYSE:AORT) with a Market Outperform and lowers the price target from $48 to $42.